Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

The effect of modifiable risk factors on breast cancer aggressiveness among black and white women.

Killelea BK, Gallagher EJ, Feldman SM, Port E, King T, Boolbol SK, Franco R, Fei K, Le Roith D, Bickell NA.

Am J Surg. 2019 Jul 18. pii: S0002-9610(19)30187-4. doi: 10.1016/j.amjsurg.2019.07.012. [Epub ahead of print]

PMID:
31375248
2.

The 2018 Compensation Survey of the American Society of Breast Surgeons.

Killelea BK, Modestino AS, Gass J, Kuerer HM, Margenthaler J, Boolbol SK, Dietz JR, Manahan ER.

Ann Surg Oncol. 2019 Oct;26(10):3052-3062. doi: 10.1245/s10434-019-07546-x. Epub 2019 Jul 24.

PMID:
31342382
3.

Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons.

Manahan ER, Kuerer HM, Sebastian M, Hughes KS, Boughey JC, Euhus DM, Boolbol SK, Taylor WA.

Ann Surg Oncol. 2019 Oct;26(10):3025-3031. doi: 10.1245/s10434-019-07549-8. Epub 2019 Jul 24.

PMID:
31342359
4.

Genomic comparison of paired primary breast carcinomas and lymph node macrometastases using the Oncotype DX Breast Recurrence Score® test.

Boolbol SK, Harshan M, Chadha M, Kirstein L, Cohen JM, Klein P, Anderson J, Davison D, Jakubowski DM, Baehner FL, Malamud S.

Breast Cancer Res Treat. 2019 Oct;177(3):611-618. doi: 10.1007/s10549-019-05346-1. Epub 2019 Jul 13.

PMID:
31302854
5.

Nipple-Sparing Mastectomy: Indications, Contraindications, Risks, Benefits, and Techniques.

Hieken TJ, Boolbol SK, Dietz JR.

Ann Surg Oncol. 2016 Oct;23(10):3138-44. doi: 10.1245/s10434-016-5370-5. Epub 2016 Jul 12. Review. No abstract available.

PMID:
27406096
6.

Factors influencing incidence and type of postmastectomy breast reconstruction in an urban multidisciplinary cancer center.

Iskandar ME, Dayan E, Lucido D, Samson W, Sultan M, Dayan JH, Boolbol SK, Smith ML.

Plast Reconstr Surg. 2015 Feb;135(2):270e-6e. doi: 10.1097/PRS.0000000000000888.

PMID:
25626810
7.

Clinical significance of HER2-positive and triple-negative status in small (≤ 1 cm) node-negative breast cancer.

Gorshein E, Klein P, Boolbol SK, Shao T.

Clin Breast Cancer. 2014 Oct;14(5):309-14. doi: 10.1016/j.clbc.2014.02.007. Epub 2014 Mar 3.

PMID:
24703318
8.

A randomized prospective study of lumpectomy margin assessment with use of MarginProbe in patients with nonpalpable breast malignancies.

Schnabel F, Boolbol SK, Gittleman M, Karni T, Tafra L, Feldman S, Police A, Friedman NB, Karlan S, Holmes D, Willey SC, Carmon M, Fernandez K, Akbari S, Harness J, Guerra L, Frazier T, Lane K, Simmons RM, Estabrook A, Allweis T.

Ann Surg Oncol. 2014 May;21(5):1589-95. doi: 10.1245/s10434-014-3602-0. Epub 2014 Mar 5.

9.

Effects of adjuvant chemotherapy in HER2-positive or triple-negative pT1ab breast cancers: a multi-institutional retrospective study.

Olszewski AJ, Migdady Y, Boolbol SK, Klein P, Boachie-Adjei K, Sakr BJ, Sikov W, Shao T.

Breast Cancer Res Treat. 2013 Feb;138(1):215-23. doi: 10.1007/s10549-013-2423-3. Epub 2013 Jan 26.

PMID:
23354365
10.

Early-stage breast cancer treated with 3-week accelerated whole-breast radiation therapy and concomitant boost.

Chadha M, Woode R, Sillanpaa J, Lucido D, Boolbol SK, Kirstein L, Osborne MP, Feldman S, Harrison LB.

Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):40-4. doi: 10.1016/j.ijrobp.2012.11.010. Epub 2013 Jan 4.

PMID:
23290443
11.

Is there a role for postmastectomy radiation therapy in ductal carcinoma in situ?

Chadha M, Portenoy J, Boolbol SK, Gillego A, Harrison LB.

Int J Surg Oncol. 2012;2012:423520. doi: 10.1155/2012/423520. Epub 2012 Jun 13.

12.

Postsurgical treatment of early-stage breast cancer with electronic brachytherapy: outcomes and health-related quality of life at 1 year.

Patel RR, Beitsch PD, Nichols TD, Lorenzetti JD, Wurzer JC, Tucker JC, Nunn GW, Laduzinsky SJ, Kugler MA, Simmons DL, Gilligan MS, Roy T, Foley JK, Thropay JP, Odou MW, Bornstein BA, Tito EP, Chadha M, Boolbol SK, Lane SC, White JG.

Am J Clin Oncol. 2013 Oct;36(5):430-5. doi: 10.1097/COC.0b013e31825493bb.

PMID:
22706177
13.

Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer.

Chadha M, Vongtama D, Friedmann P, Parris C, Boolbol SK, Woode R, Harrison LB.

Clin Breast Cancer. 2012 Feb;12(1):57-62. doi: 10.1016/j.clbc.2011.09.002. Epub 2011 Nov 6.

PMID:
22056970
14.

MRI versus breast-specific gamma imaging (BSGI) in newly diagnosed ductal cell carcinoma-in-situ: a prospective head-to-head trial.

Keto JL, Kirstein L, Sanchez DP, Fulop T, McPartland L, Cohen I, Boolbol SK.

Ann Surg Oncol. 2012 Jan;19(1):249-52. doi: 10.1245/s10434-011-1848-3. Epub 2011 Jul 8.

PMID:
21739318
15.

Surgical perspectives from a prospective, nonrandomized, multicenter study of breast conserving surgery and adjuvant electronic brachytherapy for the treatment of breast cancer.

Dooley WC, Algan O, Dowlatshahi K, Francescatti D, Tito E, Beatty JD, Lerner AG, Ballard B, Boolbol SK.

World J Surg Oncol. 2011 Mar 7;9:30. doi: 10.1186/1477-7819-9-30.

16.

George Peters Award: How does breast-specific gamma imaging affect the management of patients with newly diagnosed breast cancer?

Killelea BK, Gillego A, Kirstein LJ, Asad J, Shpilko M, Shah A, Feldman S, Boolbol SK.

Am J Surg. 2009 Oct;198(4):470-4. doi: 10.1016/j.amjsurg.2009.06.016.

PMID:
19800450
17.

Intraoperative high-dose-rate brachytherapy--a novel technique in the surgical management of axillary recurrence.

Chadha M, Mehta P, Feldman S, Boolbol SK, Harrison LB.

Breast J. 2009 Mar-Apr;15(2):140-5. doi: 10.1111/j.1524-4741.2009.00688.x.

PMID:
19292799
18.

Quality assurance initiative at one institution for minimally invasive breast biopsy as the initial diagnostic technique.

Clarke-Pearson EM, Jacobson AF, Boolbol SK, Leitman IM, Friedmann P, Lavarias V, Feldman SM.

J Am Coll Surg. 2009 Jan;208(1):75-8. doi: 10.1016/j.jamcollsurg.2008.09.008. Epub 2008 Nov 7.

PMID:
19228506
19.

The role of mammary ductoscopy in breast cancer: a review of the literature.

Kapenhas-Valdes E, Feldman SM, Boolbol SK.

Ann Surg Oncol. 2008 Dec;15(12):3350-60. doi: 10.1245/s10434-008-9911-4. Epub 2008 Oct 8. Review.

PMID:
18841418
20.

Do additional shaved margins at the time of lumpectomy eliminate the need for re-excision?

Jacobson AF, Asad J, Boolbol SK, Osborne MP, Boachie-Adjei K, Feldman SM.

Am J Surg. 2008 Oct;196(4):556-8. doi: 10.1016/j.amjsurg.2008.06.007.

PMID:
18809063
21.

Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?

Asad J, Jacobson AF, Estabrook A, Smith SR, Boolbol SK, Feldman SM, Osborne MP, Boachie-Adjei K, Twardzik W, Tartter PI.

Am J Surg. 2008 Oct;196(4):527-9. doi: 10.1016/j.amjsurg.2008.06.021.

PMID:
18809056
22.

Mammary ductoscopy for evaluation of nipple discharge.

Kapenhas-Valdes E, Feldman SM, Cohen JM, Boolbol SK.

Ann Surg Oncol. 2008 Oct;15(10):2720-7. doi: 10.1245/s10434-008-0012-1. Epub 2008 Aug 7.

PMID:
18685898
23.

Reoperative sentinel lymph node biopsy in patients with locally recurrent breast cancer.

Barone JL, Feldman SM, Estabrook A, Tartter PI, Rosenbaum Smith SM, Boolbol SK.

Am J Surg. 2007 Oct;194(4):491-3.

PMID:
17826062
24.

Intraoperative touch preparation cytology for margin assessment in breast-conservation surgery: does it work for lobular carcinoma?

Valdes EK, Boolbol SK, Ali I, Feldman SM, Cohen JM.

Ann Surg Oncol. 2007 Oct;14(10):2940-5. Epub 2007 Jul 14.

PMID:
17632761
25.

Papillary lesions: a review of the literature.

Valdes EK, Feldman SM, Boolbol SK.

Ann Surg Oncol. 2007 Mar;14(3):1009-13. Epub 2007 Jan 7. Review. No abstract available.

PMID:
17206486
26.

Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?

Valdes EK, Boolbol SK, Cohen JM, Feldman SM.

Ann Surg Oncol. 2007 Mar;14(3):1045-50. Epub 2007 Jan 6.

PMID:
17206481
27.

Less is more: transmammary axillary lymph node evaluation: an initial clinical experience.

Cocilovo C, Boolbol SK, Valdes E, Feldman S.

Am J Surg. 2006 Oct;192(4):478-80.

PMID:
16978953
28.

Clinical Experience With Mammary Ductoscopy.

Valdes EK, Boolbol SK, Cohen JM, Balassanian R, Feldman SM.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):9015-9019. Epub 2006 Jul 29.

PMID:
16897273
29.

Diagnosis of recurrent breast cancer by ductoscopy.

Valdes EK, Feldman SM, Balassanian R, Cohen JM, Boolbol SK.

Breast J. 2005 Nov-Dec;11(6):506. No abstract available.

PMID:
16297117
30.

Malignant transformation of a breast fibroadenoma to cystosarcoma phyllodes: case report and review of the literature.

Valdes EK, Boolbol SK, Cohen JM, Feldman SM.

Am Surg. 2005 Apr;71(4):348-53. Review. No abstract available.

PMID:
15943412
31.

Association of breast cancer with papillary lesions identified at percutaneous image-guided breast biopsy.

Gendler LS, Feldman SM, Balassanian R, Riker MA, Frencher SK, Whelan DB, Anne S, Gross JD, Cohen JM, Boolbol SK.

Am J Surg. 2004 Oct;188(4):365-70.

PMID:
15474427
32.

Myofibroblastoma of the breast.

Lichten JB, Boolbol SK, Feldman SM, Friedman I.

Breast J. 2004 Jul-Aug;10(4):370-1. No abstract available.

PMID:
15239801
33.

Postlactational microcalcifications.

Giron GL, Boolbol SK, Gross J, Cohen JM, Feldman S.

Breast J. 2004 May-Jun;10(3):247-52.

PMID:
15125754
34.

Sentinel lymph node biopsy: an American perspective.

Boolbol SK, Borgen PI.

Breast. 2001 Aug;10(4):287-90.

PMID:
14965596
35.

A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy.

Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, Borgen PI, Cody HS 3rd, Kattan MW.

Ann Surg Oncol. 2003 Dec;10(10):1140-51.

PMID:
14654469
36.

Randomized clinical trials in breast cancer.

Klauber-Demore N, Boolbol SK, Derossis AM, Ruo L, Bernik SF, Borgen PI.

Surg Oncol Clin N Am. 2002 Jan;11(1):53-88, viii. Review.

PMID:
11928802
37.

Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.

Boolbol SK, Fey JV, Borgen PI, Heerdt AS, Montgomery LL, Paglia M, Petrek JA, Cody HS 3rd, Van Zee KJ.

Ann Surg Oncol. 2001 Jan-Feb;8(1):20-4.

PMID:
11206219
38.

The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis.

Mahmoud NN, Boolbol SK, Dannenberg AJ, Mestre JR, Bilinski RT, Martucci C, Newmark HL, Chadburn A, Bertagnolli MM.

Carcinogenesis. 1998 Jan;19(1):87-91.

PMID:
9472698
39.

Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration.

Mahmoud NN, Boolbol SK, Bilinski RT, Martucci C, Chadburn A, Bertagnolli MM.

Cancer Res. 1997 Nov 15;57(22):5045-50.

40.

Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.

Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, Abreu-Goris M, Newmark HL, Lipkin ML, DeCosse JJ, Bertagnolli MM.

Cancer Res. 1996 Jun 1;56(11):2556-60.

Supplemental Content

Loading ...
Support Center